Loading data
PPCBNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Research and development expense | 625.48 k USD | 223.72 k USD | 248.1 k USD | 247.92 k USD | 256.05 k USD |
| Operating profit | -18.19 m USD | -57.28 m USD | -1.54 m USD | -1.78 m USD | -1.99 m USD |
| Interest expense | — | — | — | 532.82 k USD | 568.8 k USD |
| Profit before tax | -18.86 m USD | -58.92 m USD | -1.95 m USD | -2.79 m USD | -2.71 m USD |
| Income tax expense | — | — | -129.13 k USD | -129.84 k USD | -54.98 k USD |
| Net income (reported basis) | -18.86 m USD | -58.92 m USD | -1.82 m USD | -2.66 m USD | -2.66 m USD |
| Net income attributable to common shareholders | -19.79 m USD | -58.92 m USD | -2.01 m USD | -3.13 m USD | -3.36 m USD |
| Basic earnings per share | -17.62 USD/share | -371.22 USD/share | -35,324.35 USD/share | -107,896.32 USD/share | -49.23 USD/share |
| Diluted earnings per share | -17.62 USD/share | -371.22 USD/share | -35,324.35 USD/share | -107,896.32 USD/share | -49.23 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.